Pennsylvania’s state budget fight this year will largely be dictated by the rising cost of caring for an aging and sicker ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.